par Eschenhagen, Thomas;Force, Thomas;Ewer, Michael S;de Keulenaer, Gilles W;Suter, Thomas;Anker, Stefan D;Avkiran, Metin;de Azambuja, Evandro 
;Balligand, Jean-Luc;Brutsaert, Dirk L;Condorelli, Gianluigi;Hansen, Arne;Heymans, Stephane;Hill, Joseph A;Hirsch, Emilio;Hilfiker-Kleiner, Denise;Janssens, Stef ;de Jong, Steven;Neubauer, Gitte;Pieske, Burkert;Ponikowski, Piotr;Pirmohamed, Munir;Rauchhaus, Mathias;Sawyer, Douglas;Sugden, Peter H;Wojta, Johann;Zannad, Faiez;Shah, Ajay M
Référence European journal of heart failure, 13, 1, page (1-10)
Publication Publié, 2011-01
;Balligand, Jean-Luc;Brutsaert, Dirk L;Condorelli, Gianluigi;Hansen, Arne;Heymans, Stephane;Hill, Joseph A;Hirsch, Emilio;Hilfiker-Kleiner, Denise;Janssens, Stef ;de Jong, Steven;Neubauer, Gitte;Pieske, Burkert;Ponikowski, Piotr;Pirmohamed, Munir;Rauchhaus, Mathias;Sawyer, Douglas;Sugden, Peter H;Wojta, Johann;Zannad, Faiez;Shah, Ajay MRéférence European journal of heart failure, 13, 1, page (1-10)
Publication Publié, 2011-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Eschenhagen, Thomas; Force, Thomas; Ewer, Michael S; de Keulenaer, Gilles W; Suter, Thomas; Anker, Stefan D; Avkiran, Metin; de Azambuja, Evandro; Balligand, Jean-Luc; Brutsaert, Dirk L; Condorelli, Gianluigi; Hansen, Arne; Heymans, Stephane; Hill, Joseph A; Hirsch, Emilio; Hilfiker-Kleiner, Denise; Janssens, Stef; de Jong, Steven; Neubauer, Gitte; Pieske, Burkert; Ponikowski, Piotr; Pirmohamed, Munir; Rauchhaus, Mathias; Sawyer, Douglas; Sugden, Peter H; Wojta, Johann; Zannad, Faiez; Shah, Ajay M |
| Informations sur la publication: | European journal of heart failure, 13, 1, page (1-10) |
| Statut de publication: | Publié, 2011-01 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | Anthracyclines |
| Cardio-oncology | |
| Cardiotoxicity | |
| Consensus statement | |
| Heart failure | |
| Targeted therapy | |
| MeSH keywords: | Anthracyclines -- adverse effects -- therapeutic use |
| Antibodies, Monoclonal -- adverse effects -- therapeutic use | |
| Antibodies, Monoclonal, Humanized | |
| Antineoplastic Agents -- adverse effects -- therapeutic use | |
| Cardiology -- standards | |
| Cardiotoxins | |
| Cardiovascular System -- drug effects | |
| Education | |
| Europe | |
| Heart Failure -- chemically induced | |
| Humans | |
| Neoplasms -- drug therapy | |
| Practice Guidelines as Topic | |
| Receptor, Epidermal Growth Factor -- drug effects | |
| Risk Factors | |
| Sirolimus -- antagonists & inhibitors | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| FLWIN | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1388-9842 |
| info:doi/10.1093/eurjhf/hfq213 | |
| info:pii/hfq213 | |
| info:scp/78650383580 | |
| info:pmid/21169385 |
